Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
About Aurinia
Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS ® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing AUR200, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Benchmark Reaffirms ‘Buy' Rating on QUALCOMM Incorporated (QCOM) With $200 PT
With strong hedge fund interest and a low price-to-earnings ratio, QUALCOMM Incorporated (NASDAQ:QCOM) secures a place on our list of the . A technician installing high-speed internet cables. On July 31, 2025, Benchmark reaffirmed its 'Buy' rating and $200 price target on QUALCOMM Incorporated (NASDAQ:QCOM). This reiteration comes despite a dip in after-hours trading. The bullish stance is attributed to the company's strong quarterly results, where the Automotive segment recorded 21% year-over-year growth. The IoT segment climbed 24%, while the Handsets segment recorded a 7% growth, thanks to strong Snapdragon 8 Elite demand in premium devices. Despite the eventual loss of Apple business, the investment firm highlighted QUALCOMM Incorporated (NASDAQ:QCOM)'s diversification strategy, which resulted in the Automotive segment's quarterly contribution of $1 billion and the IoT segment's contribution of $1.7 billion. The analyst believes the after-hours dip was due to the company's EPS guidance, which failed to surpass Street's estimates. Operating across Chipset, Technology Licensing, and Strategic Investment segments, QUALCOMM Incorporated (NASDAQ:QCOM) delivers foundational wireless technologies. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of QCOM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Gold Penny Stocks to Buy According to Hedge Funds and 11 Best Rebound Stocks to Buy According to Hedge Funds. Disclosure: None.
Yahoo
an hour ago
- Yahoo
Mizuho Reduces PT on PayPal Holdings, Inc. (PYPL)
With strong hedge fund interest and a low price-to-earnings ratio, PayPal Holdings, Inc. (NASDAQ:PYPL) secures a place on our list of the . Following the company's Q2 earnings release, Mizuho reduced its price target on PayPal Holdings, Inc. (NASDAQ:PYPL) from $87 to $84 on July 30, 2025. The analyst attributed the price revision to a slight dip in branded checkout growth and softer-than-expected transaction margin dollar guidance for the second half of 2025. Meanwhile, the company's core PayPal button business delivered strong performance when 'Buy Now Pay Later' and 'Pay with Venmo' segments are included. The latter segment is estimated to deliver 1.5 times the company-wide transaction margin. Furthermore, Barclays maintained its 'Buy' rating on PayPal Holdings, Inc. (NASDAQ:PYPL) on July 30 with a $90 target, and Needham maintained a 'Hold' rating the same day. Needham cited short-term e-commerce headwinds and modest EPS growth expectations. With its global technology platform, PayPal Holdings, Inc. (NASDAQ:PYPL) allows consumers to send, receive, and manage digital payments through multiple funding sources and channels. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of PYPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Yahoo
an hour ago
- Yahoo
Apple Inc. (AAPL) Announces New Releases in Apple Arcade Segment
With a year-to-date decline in share price, along with strong hedge fund interest, Apple Inc. (NASDAQ:AAPL) secures a place on our list of the . brandon-romanchuk-NOFyRmSQfUQ-unsplash On August 12, 2025, Apple Inc. (NASDAQ:AAPL) announced new releases in its Apple Arcade segment, reinforcing its strategy to grow recurring revenue streams beyond hardware sales. As per the announcement, NFL Retro Bowl '26 will release on September 3, featuring a new Championship Leadership mode, which is synced with real NFL matchups. Also, Jeopardy! Daily and My Talking Tom Friends+ will be released on the same day. Featuring new characters and quests, Hello Kitty Island Adventure will launch its 'Wheatflour Wonderland' update later in the month. Looking ahead, Apple Inc. (NASDAQ:AAPL)'s long-term growth strategy is driven by its Apple Arcade's evolving catalog, offering over 200 ad-free games. Across its products like iPhone, iPad, Mac, and Apple TV, Apple Inc. (NASDAQ:AAPL) offers unlimited access to over 200 premium, ad-free games through its subscription-based gaming service, Apple Arcade. It is included in our list of the Best Rebound Stocks To Buy. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
